VERAMORPH
VeraMorph is a pharmaceutical company that is developing an oral dosage technology based on polymers. The company was founded in 2017 and is headquartered in Mansfield, Massachusetts.
VERAMORPH
Social Links:
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2017-01-01
Address:
Mansfield, Massachusetts, United States
Country:
United States
Website Url:
http://www.veramorph.com
Total Employee:
1+
Status:
Active
Contact:
617-657-9914
Total Funding:
225 K USD
Technology used in webpage:
Euro Google Google Cloud Wix
Similar Organizations
Affinivax
Affinivax is a biopharmaceutical company developing vaccines that target infectious diseases.
BionPharma
BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships.
Carisma Therapeutics
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
Disc Medicine
Disc Medicine is a hematology company
Eden Biologics
Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.
LucasPye BIO
A Contract Development and Manufacturing Organization (CDMO) that manufactures protein-therapeutic and viral-therapeutic drug products.
PerioTrap Pharmaceuticals GmbH
PerioTrap is an early stage biopharmaceutical company that aims to eradicate the root cause of periodontitis
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Current Employees Featured
Founder
Investors List
National Science Foundation
National Science Foundation investment in Grant - Veramorph
Official Site Inspections
http://www.veramorph.com
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 75.2.70.75
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Veramorph"
Home | VeraMorph
VeraMorph was founded on and operates with the mission to prolong and improve the quality of life of patients, regardless of indication. To achieve this goal, VeraMorph is led by a team of …See details»
Veramorph - Crunchbase Company Profile & Funding
Organization. Veramorph . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... VeraMorph is a …See details»
VeraMorph 2025 Company Profile: Valuation, Funding & Investors
VeraMorph General Information Description. Developer of an oral drug delivery technology designed to provide contract manufacturing and formulation services using proprietary oral …See details»
Veramorph LLC - National Science Foundation
These topic labels come from the works of this organization's members. Together they form a unique fingerprint. Solution and Solubility Biochemistry, Genetics and Molecular ... Veramorph …See details»
VeraMorph Inc. (CIK: 0001944210) EDGAR, Information, Filings ...
VeraMorph Inc. (CIK: 0001944210) is an American company incorporated in the state of Massachusetts.Head office is located at C/O MANSFIELD-BIO, 241 FRANCIS AVENUE, …See details»
Veramorph LLC - VentureRadar
VeraMorph is expanding oral delivery of poorly soluble drugs with a proprietary oral solid dosage technology. Disintegrating Pre-formed Oral Dosages (DPODs) simplify drug product design …See details»
VeraMorph | F6S
VeraMorph is an oral drug delivery company improving drug solubility. Its products are reformulations of poorly soluble, approved small molecule therapeutics. VeraMorph is utilizing …See details»
Veramorph LLC Company Profile | Norwood, MA - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Veramorph LLC of Norwood, MA. Get the latest business insights from Dun & Bradstreet.See details»
Doug Godfrin - Founder & CEO - VeraMorph | LinkedIn
Founder & CEO at VeraMorph · Scientist entrepreneur dedicated to enhancing prescription drug development. My expertise and interests lie in colloidal science, pharmaceutical formulations, …See details»
About Us - VeraMorph
VeraMorph is a pre-clinical strategic pharmaceutical company driven by the mission of prolonging and improving patient lives by maximizing the therapeutic potential of any and all therapeutic …See details»
VeraMorph, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Feb 5, 2025 Explore VeraMorph, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»
Veramorph - Funding, Financials, Valuation & Investors - Crunchbase
VeraMorph is a pharmaceutical company that is developing an oral dosage technology based on polymers. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. ... How much …See details»
Portfolio | VeraMorph
VeraMorph's DPOD platform is uniquely capable of nearly universal compatibility with poorly soluble drug substances. Considering about 40% of approved drug products are poorly …See details»
Veramorph - Contacts, Employees, Board Members, Advisors
VeraMorph is a pharmaceutical company that is developing an oral dosage technology based on polymers. New. Resources. ... Experience the new Crunchbase, powered by AI . Organization. …See details»
Contact Us - VeraMorph
Thank you for your interest in VeraMorph. To contact us please reach us via:See details»
Fulvestrant - VeraMorph - AdisInsight - Springer
If your organization has a subscription, there are several access options, even while working remotely: Working within your organization’s network Login with username/password or try to …See details»
Veramorph - Tech Stack, Apps, Patents & Trademarks - Crunchbase
VeraMorph is a pharmaceutical company that is developing an oral dosage technology based on polymers. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log …See details»
Science | VeraMorph
VeraMorph leverages its innovative oral drug delivery platform technology to rapidly design effective oral dosages of a given drug substance to generate pre-clinical proof of concept data. …See details»
Ontario Welcomes GE Vernova Hitachi’s $70 Million ... - Ontario …
2 days ago - Ivette Vera-Perez President and CEO, Organization of Canadian Nuclear Industries "This is another sign of the tremendous progress OPG and GE Vernova Hitachi are making on …See details»
Science | VeraMorph
A large amount of newly discovered (roughly 90%) and approved (roughly 40%) small molecule drugs suffer from poor solubility, which limits their effectiveness when delivered orally due to …See details»